4//SEC Filing
SCHREIBER ALAIN 4
Accession 0000932440-17-000088
CIK 0001668243other
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 5:07 PM ET
Size
11.7 KB
Accession
0000932440-17-000088
Insider Transaction Report
Form 4
SCHREIBER ALAIN
10% Owner
Transactions
- Sale
Ordinary Shares, par value NIS 0.01 per share
2017-11-28$40.51/sh−177,807$7,202,962→ 1,242,031 total - Sale
Ordinary Shares, par value NIS 0.01 per share
2017-11-27$41.12/sh−31,491$1,294,910→ 1,419,838 total
Moorin Jay
10% Owner
Transactions
- Sale
Ordinary Shares, par value NIS 0.01 per share
2017-11-28$40.51/sh−177,807$7,202,962→ 1,242,031 total - Sale
Ordinary Shares, par value NIS 0.01 per share
2017-11-27$41.12/sh−31,491$1,294,910→ 1,419,838 total
ProQuest Investments IV, L.P.
10% Owner
Transactions
- Sale
Ordinary Shares, par value NIS 0.01 per share
2017-11-27$41.12/sh−31,491$1,294,910→ 1,419,838 total - Sale
Ordinary Shares, par value NIS 0.01 per share
2017-11-28$40.51/sh−177,807$7,202,962→ 1,242,031 total
ProQuest Associates IV LLC
10% Owner
Transactions
- Sale
Ordinary Shares, par value NIS 0.01 per share
2017-11-27$41.12/sh−31,491$1,294,910→ 1,419,838 total - Sale
Ordinary Shares, par value NIS 0.01 per share
2017-11-28$40.51/sh−177,807$7,202,962→ 1,242,031 total
Footnotes (3)
- [F1]The securities are directly held by ProQuest Investments IV, L.P. and indirectly held by ProQuest Associates IV, LLC, the General Partner of ProQuest Investments IV, L.P. The individual managing members of ProQuest Associates IV, LLC are Jay Moorin and Alain Schreiber, M.D., who may be deemed to have shared voting and investment and dispositive power with respect to these shares. Each individual managing member disclaims beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares.
- [F2]Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $41.00 to $41.68. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.
- [F3]Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $40.50 to $41.01. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001225149
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 5:07 PM ET
- Size
- 11.7 KB